ÂÜÀòÂÒÂ×

Gulhan Demirci is an experienced professional in the biotechnology and pharmaceuticals sectors, currently serving as Chief Innovation Officer at Pharmako Biotechnologies Pty Ltd since November 2024. In addition, Gulhan holds significant positions at Complementary Medicines Australia as Chairperson of the GMP Committee and Board Member since September 2019. Previous roles include Chief Innovation Officer and Innovation and NPD Manager at Lipa Pharmaceuticals Limited, as well as Head of Product at Unichi. With a strong foundation in research and development, Gulhan has worked at organizations such as Caruso's Natural Health, 3M, CSR Limited, and UNSW, contributing to various areas including technical and regulatory affairs, product development, and scientific research. Educational credentials include a Bachelor of Applied Science in Biology from Western Sydney University.